OraSure Technologies to Present at UBS Warburg Global Life Sciences Conference

BETHLEHEM, Pa.--(BUSINESS WIRE)--Oct. 5, 2001--OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Robert D. Thompson, Chief Executive Officer, will be presenting at the UBS Warburg Global Life Sciences Conference on Monday, October 8, at 11:30 a.m. (Eastern).

This conference will be held at the Pierre Hotel, New York, New York.

UBS Warburg will be providing listen-only dial-in conference lines for public access to the presentation. Additionally, the conference call will be archived for four weeks following the conference. The telephone numbers are:

         Live:        +1-800-500-0177 (domestic) and
                      +1-719-457-2679 (international)
         Archived:    +1-800-759-8603 (domestic) and
                      +1-402-220-8537 (international)

About OraSure

OraSure Technologies, Inc. develops, manufactures and markets medical devices and diagnostic products for use by public- and private-sector clients, clinical laboratories, physicians' offices, and workplace testing. OraSure Technologies is the leading supplier of oral fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV.

In addition, the Company supplies oral fluid testing solutions for drugs of abuse testing. For more information on the Company, please visit www.orasure.com.

www.orasure.com